| P50 | author | Kamryn T Eddy | Q89928788 |
| | Debra L Franko | Q104536314 |
| | Aparna Keshaviah | Q114079536 |
| P2093 | author name string | David Mischoulon | |
| | David B Herzog | |
| | Andrea E Kass | |
| | Stephanie L Ross | |
| | Diana Dinescu | |
| P2860 | cites work | Initial severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug Administration | Q21092366 |
| | Active placebos versus antidepressants for depression | Q24247474 |
| | An Inventory for Measuring Depression | Q26778503 |
| | No adjustments are needed for multiple comparisons | Q28292261 |
| | Recovery and relapse in anorexia and bulimia nervosa: a 7.5-year follow-up study | Q33868017 |
| | Predictors of mortality in eating disorders | Q34176381 |
| | What predicts suicide attempts in women with eating disorders? | Q34361258 |
| | Medication and psychotherapy in the treatment of bulimia nervosa | Q34420656 |
| | Fluoxetine after weight restoration in anorexia nervosa: a randomized controlled trial | Q34537911 |
| | Increased mortality in bulimia nervosa and other eating disorders | Q35008149 |
| | Emerging drugs for eating disorder treatment | Q36458423 |
| | Outcomes of eating disorders: a systematic review of the literature | Q36763731 |
| | The genetics of anorexia nervosa collaborative study: methods and sample description | Q37127485 |
| | Suicide attempts in bulimia nervosa: personality and psychopathological correlates | Q40016688 |
| | A placebo-controlled study of fluoxetine in continued treatment of bulimia nervosa after successful acute fluoxetine treatment | Q43843044 |
| | Psychiatric comorbidity in treatment-seeking anorexics and bulimics | Q44309996 |
| | The process of recovering from anorexia nervosa | Q45818234 |
| | Suicide attempts in anorexia nervosa | Q48361517 |
| | Personality traits after recovery from eating disorders: do subtypes differ? | Q50944206 |
| | Symptom profile of major depressive disorder in women with eating disorders. | Q51904291 |
| | Twelve-year course and outcome of bulimia nervosa. | Q51932893 |
| | Comorbidity of axis I psychiatric disorders in bulimia nervosa. | Q52018663 |
| | The Longitudinal Interval Follow-up Evaluation. A comprehensive method for assessing outcome in prospective longitudinal studies. | Q52074583 |
| | Long-term outcome of anorexia nervosa in a prospective 21-year follow-up study | Q61979305 |
| | Fluoxetine in the treatment of bulimia nervosa. A multicenter, placebo-controlled, double-blind trial. Fluoxetine Bulimia Nervosa Collaborative Study Group | Q68077415 |
| | Fluoxetine versus placebo: a double-blind study with bulimic inpatients undergoing intensive psychotherapy | Q70132232 |
| | Bulimia treated with imipramine: a placebo-controlled, double-blind study | Q70254558 |
| | Pharmacotherapy of bulimia nervosa with fluoxetine: assessment of clinically significant attitudinal change | Q70677253 |
| | Relationship of depression, anxiety, and obsessionality to state of illness in anorexia nervosa | Q73312396 |
| | Practice guideline for the treatment of patients with eating disorders (revision). American Psychiatric Association Work Group on Eating Disorders | Q73372599 |
| | Intensive nutritional counselling in bulimia nervosa: a role for supplementation with fluoxetine? | Q73628461 |
| | Does fluoxetine augment the inpatient treatment of anorexia nervosa? | Q74451927 |
| | Predictive factors of social disability in anorexic and bulimic patients | Q81673787 |
| | Depression, anxiety, and obsessionality in long-term recovered patients with adolescent-onset anorexia nervosa | Q95810001 |
| P433 | issue | 3 | |
| P921 | main subject | eating disorder | Q373822 |
| P304 | page(s) | 470-477 | |
| P577 | publication date | 2010-11-24 | |
| P1433 | published in | Journal of Affective Disorders | Q15716493 |
| P1476 | title | Depression and eating disorders: treatment and course | |
| P478 | volume | 130 | |